Loading...
XASXWNX
Market cap12mUSD
Jan 08, Last price  
0.68AUD
1D
-2.16%
1Q
-24.44%
IPO
-93.38%
Name

Wellnex Life Ltd

Chart & Performance

D1W1MN
XASX:WNX chart
P/E
P/S
1.23
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
-38.49%
Rev. gr., 5y
80.37%
Revenues
17m
-39.26%
455,0131,5069,978928,4261,441,000887,0001,048,0001,195,00018,607,00027,876,00016,932,000
Net income
-14m
L-0.77%
-158,140-316,291-535,586-4,150,944-19,833,000-9,911,000-43,341,000-24,965,000-7,449,000-13,846,000-13,739,000
CFO
-7m
L+10.16%
202,642-127,910-640,635-3,706,000-6,059,000-12,674,000-7,570,000-4,376,000-8,611,000-6,189,000-6,818,000
Earnings
Mar 04, 2025

Profile

Wellnex Life Limited develops health and wellness solutions in Australia. The company provides organic baby skincare products under the Little Innoscents; nutritional support products under the Performance Inspired; iron gummies under The Iron Company; organic milk under the Uganic; natural energy products under the Wakey Wakey; smooth textured capsules under the Liquigesic; and garlic products under the SupaGarlic brands. It also offers bin cleanser solutions under the Bin Buddy; medical products under the Bird Healthcare; gel plasters for treating blisters, corns, cracked heels, and cold sores under the Compeed; oral emergency contraception pills under the EllaOne; skincare solutions under the KoƩna; canned meats under the Plumrose; snacks under the Simply7; skincare products under the edited; natural herbal skincare products under the naked klay; and natural essential oil blends under the Planet Remedy brands. In addition, the company provides contract manufacturing services. Wellnex Life Limited has a collaboration with Onelife Botanicals for the manufacture, distribution, and sales of cannabis and hemp-based products. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Melbourne, Australia.
IPO date
Mar 15, 2017
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑102016‑062015‑06
Income
Revenues
16,932
-39.26%
27,876
49.81%
18,607
1,457.07%
Cost of revenue
23,579
34,715
24,357
Unusual Expense (Income)
NOPBT
(6,647)
(6,839)
(5,750)
NOPBT Margin
Operating Taxes
1,698
1,142
Tax Rate
NOPAT
(6,647)
(8,537)
(6,892)
Net income
(13,739)
-0.77%
(13,846)
85.88%
(7,449)
-70.16%
Dividends
Dividend yield
Proceeds from repurchase of equity
20,150
7,456
2,006
BB yield
-67.45%
-0.15%
Debt
Debt current
10,667
6,898
2,472
Long-term debt
52
214
5,669
Deferred revenue
Other long-term liabilities
86
98
59
Net debt
9,816
6,790
4,960
Cash flow
Cash from operating activities
(6,818)
(6,189)
(8,611)
CAPEX
6,818
(42)
Cash from investing activities
(13,420)
(2,200)
(3,645)
Cash from financing activities
20,819
5,530
7,662
FCF
1,353
(8,759)
(9,729)
Balance
Cash
903
322
3,181
Long term investments
Excess cash
56
2,251
Stockholders' equity
6,060
594
4,359
Invested Capital
16,757
7,642
9,198
ROIC
ROCE
EV
Common stock shares outstanding
23,900
8,073
397,767
Price
1.25
 
3.35
 
Market cap
29,875
 
1,332,518
 
EV
39,691
1,337,478
EBITDA
(5,826)
(6,565)
(5,603)
EV/EBITDA
Interest
2,395
1,682
956
Interest/NOPBT